Articles tagged "Liver transplantation"

2018 American Transplant Congress
Isolated Right Hepatic Vein (RHV) Obstruction after Piggyback Liver Transplantation, an Infrahepatic Terminolateral Cavo-Cavostomy as a Rescue Technique to Save the Graft
K. Pineda-Solis, C. Florez-Zorrilla, A. Sanchez-Cedillo, L. Ladrón de Guevara-Cetrina.
Transplant Unit, National Medical Center "20 de Noviembre", Mexico City, Mexico.
Background: The “piggyback” technique for liver transplantation (LT) has gained acceptance around the world. However, outflow problems are more common than the classic technique.Material and…
2018 American Transplant Congress
Development and Validation of Nomogram to Predict Primary Non Function in Liver Transplant Recipients Using Donation after Cardiac Death Donor Graft
Z. Guo, J. Zeng, Q. Zhao, B. Chen, Z. Zhang, L. Wang, X. He.
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Primary non function(PNF) is a severe complication after liver transplantation which causes recipient death or re-transplantation in a short term. PNF occurs more common in…
2018 American Transplant Congress
Association between Everolimus Trough Levels, Onset of Related Adverse Events, and Treatment Discontinuation after Liver Transplantation: 24-Month Results from the H2304 Study
J. Fung,¹ F. Saliba,¹ H. Schlitt,¹ G. Junge,² K. McCague,³ D. Patel,³ M. Charlton.¹
¹H2304 Study Group, Chicago; ²Novartis Pharma AG, Basel, Switzerland; ³Novartis Pharmaceuticals Corporation, East Hanover.
Purpose: Evaluation of mammalian target of rapamycin inhibitor (mTORi)-related adverse events (AEs) and drug trough levels (C0) at onset may aid their management in liver…
2018 American Transplant Congress
Comparison of No Kasai Portoenterstomy to Failed Kasai: Analysis of UNOS Database
T. Miloh, K. Hosek, S. Harpavath.
Texas Children's Hospital/Baylor College of Medicine, Houston.
IntroductionInfants with biliary atresia (BA) identified “later” (typically after 90 days of life) present a management challenge, as late Kasai portoenterostomy (KP) has high failure…
2018 American Transplant Congress
Effects of the Addition of Mycophenolate Mofetil on Renal Outcomes in Liver Transplant Recipients: A Single Center Review
M. Henry, M. Vacha.
Nebraska Medicine, Omaha, NE.
Purpose: To evaluate the use of mycophenolate mofetil (MMF) and its effects on renal outcomes in liver transplant recipientsMethods: Adult liver transplant recipients from September…
2018 American Transplant Congress
Impact of Aortic Abdominal Calcification among Living Donor Liver Transplant Recipients; a Retrospective Study
Y. Imaoka, M. Ohira, S. Simizu, H. Tahara, K. Ide, Y. Tanaka, H. Ohdan.
Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan.
Abdominal aortic calcification (AAC) is known as a risk factor of coronary artery disease, stroke, hyperphosphatemia, chronic inflammation, diabetes, and decreased an estimated glomerular filtration…
2018 American Transplant Congress
Efficacy of Two Valganciclovir Dosing Strategies in Intermediate and High-Risk Liver Transplant Recipients
K. Belfield,¹ M. Malinis,² E. Cohen.¹
¹Department of Pharmacy, Yale New Haven Hospital, New Haven, CT; ²Section of Infectious Diseases, Yale School of Medicine, New Haven, CT.
Purpose: There is interest in reduced dosing and duration of valganciclovir (VGCV) for cytomegalovirus (CMV) prophylaxis in liver transplant (LT) recipients to minimize side effects…
2018 American Transplant Congress
Increased Expression of CEACAM1 is Cytoprotective during Ischemia-Reperfusion Injury in Human Orthotopic Liver Transplantation
R. Sosa,¹ J. Nevarez-Mejia,¹ M. Rossetti,¹ A. Zarrinpar,² F. Kaldas,² C. Lassman,¹ B. Naini,¹ N. Datta,² R. Busuttil,² D. Gjertson,¹ J. Kupiec-Weglinski,² E. Reed.¹
¹Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA; ²Surgery, University of California, Los Angeles, Los Angeles, CA.
Background T cell exhaustion has recently been proposed as an alternative mechanism to prevent memory development and tissue damage arising during ischemia-reperfusion injury (IRI) in…
2018 American Transplant Congress
Midodrine Associated with Increased Mortality on Liver Transplant Waitlist
J. Kalil, M. Hertl, E. Schadde, J. Poirier, N. Alvey, E. Chan.
General Surgery - Transplant, Rush University Medical Center, Chicago, IL.
Background:Midodrine is an alpha-1 agonist which induces arterial and venous vasoconstriction. It prevents symptomatic hypotension and is used for treatment of refractory ascites and hepatorenal…
2018 American Transplant Congress
Living Liver Donation is Safe in Donors Heterozygous for an alpha-1 Antitrypsin Gene Mutation
T. Bittermann,¹ L. Wood,² P. Abt,² A. Shaked,² K. Olthoff,² D. Goldberg.^1,3
¹Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA; ²Division of Transplant Surgery, University of Pennsylvania, Philadelphia, PA; ³Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA.
Patients homozygous for an alpha-1 antitrypsin mutation, particularly the Pi*ZZ phenotype, develop cirrhosis and pulmonary emphysema. Those with a heterozygous phenotype are thought to have…